Industry

Leader of the French party "Unruly France", former presidential candidate Jean-Luc Melanchon, said that the country's authorities knew on the effectiveness of "Sputnik V" since November last year.

The European Commission is not going to abandon the general strategy on vaccines against COVID-19 for the European Union after Germany announced its intention to independently acquire Sputnik V.

Voronezh scientists from VSUIT have come up with a plastic based on polyvinyl alcohol, which has no taste or smell. This plastic dissolves in a few minutes.

According to media reports, Germany in April may not receive a batch of almost 900 thousand doses of coronavirus vaccine from the American company Moderna.

Chinese buyers are offered the «Genesis G80» business sedan and the first crossover of the brand «Genesis GV80».

The conclusion of contracts for the supply of the Russian vaccine against the Sputnik V coronavirus is based on the capabilities of production facilities.

According to Alexander Gintsburg, Brussels fears that the Russian vaccine will become too serious a competitor to European drugs.

The Genesis model range includes the G70, G80 and G90 sedans, as well as the GV80 and GV70 crossovers.

The capitalization of the Tesla brand reached $605 billion, for comparison, the cost of Toyota, which takes the second place, is 2.5 times less.

The San Marino authorities, thanks to the supply of the Russian Sputnik V vaccine, were able to find a way out of the difficult situation and start a campaign to vaccinate the population against COVID-19.

The position of the German government on the possible use of the Russian Sputnik V coronavirus vaccine remains unchanged, for this registration with the European Medicines Agency is required.

Russia has registered the world's first and only vaccine against COVID-19 for animals "Karnivak-Kov".

Criticism of the AstraZeneca coronavirus vaccine may have led the firm to focus on a different name, and the vaccine may now increasingly appear under the new name Vaxzevria.

The carmaker demonstrates the key innovations, that the brand plans to implement in it's models by 2025.

A Russian private equity fund and Shenzhen Yuanxing Gene-tech have agreed to produce over 60 million doses of Sputnik V vaccine in China.